David-Alexandre C. Gros, MD

David-Alexandre C. Gros, MD, is chief executive officer of Eledon Pharmaceuticals.

Articles by David-Alexandre C. Gros, MD

David-Alexandre C. Gros, MDKidney Transplantation | February 25, 2025

Eledon Pharmaceuticals CEO David-Alexandre Gros, MD, spoke about the role of CD40L blocker tegoprubart in transplantation.